CAS: 68986-76-5; Copper(I) Thiophene-2-Carboxylate

该化合物是一种多用途化学中间体,在有机合成中具有重要用途. 它提供了高纯度和稳定性,促进了制药和农用化学工业的高效反应. 它的独特结构使得复杂的有机分子能够合成,为新化合物的开发提供了关键优势.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    2-噻吩甲酸,Copper(II) Oxide 以 甲苯 作为反应溶剂,化学反应 24.0H,以80%的收率获得产物噻吩-2-甲酸亚铜(I)
    参考文献:过渡金属配合物,聚合物,混合物,组合物及有机电子器件
    标题:过渡金属配合物,聚合物,混合物,组合物及有机电子器件
    摘要:本发明公开了一种过渡金属配合物,聚合物,混合物,组合物及有机电子器件.该过渡金属配合物,具有如化学式(1)所示的结构通式,其合成简单,结构新颖,同时具有较好的稳定性,寿命长,发光性能好,化学式(1)便于实现高效,高亮度,高稳定的oled器件,对全彩显示和照明应用提供了较好的材料选项..

    海关参考信息

    专利信息


    专利号:US-2016317682-A1
    优先权日:2015-04-30
    标题:PREPARATION OF Ag18F AND ITS USE IN THE SYNTHESIS OF PET RADIOTRACERS
    发明人:SCOTT PETER J H; BROOKS ALLEN F; ICHIISHI NAOKO; SANFORD MELANIE S
    权利人:UNIV MICHIGAN REGENTS; THE REGENTS OFTHE UNIV OF MICHIGAN
    摘要:Copper-catalyzed radiofluorination of aryl iodides using Ag 18 F, methods of preparing Ag 18 F, and compounds obtained by copper-catalyzed radiofluorination of aryl iodides using Ag 18 F are disclosed. Diagnostic and therapeutic methods involving such compounds also are disclosed.

    专利号:US-10829792-B2
    优先权日:2017-03-21
    标 题 :Biocatalytic synthesis of strained carbocycles
    发明人:CHEN KAI; HUANG XIONGYI; KAN S B JENNIFER
    权利人:CALIFORNIA INST OF TECHN
    摘要:Provided herein are methods for producing products containing strained carbocycles, such as cyclopropene moieties and/or bicyclobutane moieties. The methods include combining an alkyne and a carbene precursor in the presence of a heme protein, e.g., a cytochrome P450, under conditions sufficient to form the strained carbocycle. Reaction mixtures for producing strained carbocycles are also described, as well as whole-cell catalysts comprising heme proteins and variants thereof for forming cyclopropenes, bicyclobutanes, and related products.

    专利号:US-2009076268-A1
    优先权日:2007-09-14
    标 题:Facile assembly of fused benzofuro-heterocycles
    发明人:FITZGERALD ANNE E; LIU JING; MANI NEELAKANDHA S
    权利人:FITZGERALD ANNE E; LIU JING; MANI NEELAKANDHA S
    摘要:This invention concerns the synthesis of polycyclic structural components of pharmacological compounds, including the synthesis of fused benzofuro-heterocycles, through selective palladium-catalyzed cross-coupling and intramolecular cyclization.

    专利号:US-2024309003-A1
    优先权日:2021-05-04
    标题 :Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
    发明人:HOUZE JONATHAN B; BOS MAXENCE; MANCUSO JOHN; FRANZONI IVAN; PANDYA BHAUMIK; KAPLAN ALAN
    权利人:VIGIL NEUROSCIENCE INC
    摘要:The present disclosure provides compounds of Formula I, useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 (“TREM2â€?). This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula I.

    专利号:US-2024308959-A1
    优先权日:2021-06-29
    标 题:Processes for the preparation of (s)-2-(4-chloro-2-methoxyphenyl)-2-((3 -methoxy-5-(m ethylsulfonyl)phenyl)amino)-1 -(1h-indol-3-yl)ethenone derivatives
    发明人:WU KAI; OOST RIK; SCHWEITZER-CHAPUT BERTRAND; ERIKSSON CARL ARNE MAGNUS; COESEMANS ERWIN
    权利人:JANSSEN PHARMACEUTICALS INC
    摘要:The present invention relates to novel chiral synthesis of mono- or di-substituted indole compounds of formula (I) n n n n n n n n n n n n wherein: n R 1 is H, R 2 is F and R 3 is H or CH 3 , n R 1 is H, CH 3 or F, R 2 is OCH 3 and R 3 is H and n R 1 is H, R 2 is OCH 3 and R 3 is CH 3 , n R 1 is CH 3 , R 2 is F and R 3 is H, n R 1 is CF 3 or OCF 3 , R 2 is H and R 3 is H, n R 1 is OCF 3 , R 2 is OCH 3 and R 3 is H and n R 1 is OCF 3 , R 2 is H and R 3 is CH 3 .

    专利号:WO-2024233848-A1
    优先权日:2023-05-10
    标 题:Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
    发明人:HOUZE JONATHAN B; PANDYA BHAUMIK
    权利人:VIGIL NEUROSCIENCE INC
    摘要:The present disclosure provides compounds useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 ('TREM2'). This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (I).
    郑州长宽科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.changkuantech.com/
    电话: 0371-63769919 18530983798👤
    📞郑州长宽科技有限公司 ⚠️参考联系方式

    销售电话:0371-63769919 18530983798
    邮箱:sales5@changkuantech.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知